GLP-1 Telehealth: What Prescribers Need to Know in Pennsylvania

You’ve spent years mastering psychiatric care. Now there’s a massive patient demand you might not have expected: weight-loss medication management.

By 2025, roughly 6% of Americans—about 20 million people—were actively taking GLP-1 drugs like semaglutide (Ozempic/Wegovy) or tirzepatide. That’s a 600% increase in obesity-related use over just six years. And here’s the opportunity: there aren’t nearly enough providers to meet this demand.

As a psychiatrist, you’re already uniquely positioned to fill this gap. Many of your current patients struggle with medication-induced weight gain. You understand behavior change, motivation, and the mental health factors that make or break long-term weight management. You’re comfortable with telehealth. And unlike most weight-loss clinics, you can address the psychological side of obesity—which is often the missing piece.

The question isn’t whether there’s demand. It’s whether you can scale a GLP-1 practice without overextending yourself.

This guide breaks down exactly how to do it: acquiring patients efficiently, navigating telehealth compliance, and building workflows that scale without burning you out.

The Patient Acquisition Reality: Why GLP-1 Is Different

The Market Fundamentals

Nearly half of psychiatrists were already prescribing or recommending GLP-1 medications by late 2023, often to address antipsychotic-induced weight gain or comorbid obesity in their existing patients. But the broader opportunity extends far beyond your current caseload.

With 75% of Americans overweight or obese, and only a fraction having access to obesity medicine specialists, the patient pool is enormous. Tens of thousands of new patients start GLP-1 treatment every week. Many can’t find providers, face months-long waitlists at specialty clinics, or prefer working with a clinician who understands the mental health dimensions of weight management.

Where Your Existing Patients Fit In

Start with who you already know. Review your current psychiatric caseload and identify patients who:

• Have gained significant weight on psychiatric medications
• Meet FDA criteria for GLP-1s (BMI ≥30, or ≥27 with comorbidities like hypertension or diabetes)
• Express frustration about weight or have asked about weight-loss options
• Show signs of binge eating, emotional eating, or depression related to body image

Bringing up GLP-1 treatment during medication reviews is often welcomed. You’re not cold-calling strangers—you’re offering a solution to a problem your patients already have. Many will jump at the chance to address weight gain that’s been undermining their psychiatric progress.

This ‘internal referral’ approach generates revenue without additional marketing spend and deepens patient relationships. You’re treating the whole person, not just their psychiatric diagnosis.

External Patient Acquisition: The Real Economics

Here’s what most content won’t tell you: acquiring new GLP-1 patients through traditional marketing is expensive and uncertain.

If you go the DIY route—SEO, Google Ads, directory listings—you’re looking at:

• $200-500+ per qualified patient when you factor in agency fees, ad spend, staff time qualifying leads, no-show rates, and failed campaigns
• 6-12 months before SEO investment generates meaningful patient flow
• $15-40+ per click on Google Ads for mental health and weight-loss keywords, with most clicks never converting to bookings
• Monthly directory fees (Psychology Today, Zocdoc) where you compete with hundreds of other providers and still pay $35-100+ per booking on top of subscription costs

Most solo providers don’t have the expertise, budget, or patience to make this work. You’re gambling $3,000-5,000/month on marketing channels with no guaranteed ROI.

The smarter economics: Platforms like Klarity Health operate on a pay-per-appointment model. You pay a standard listing fee per new patient lead—only when a qualified patient actually books with you. No upfront marketing spend. No monthly subscriptions. No wasted ad budget on clicks that don’t convert.

The key value propositions:

• Pre-qualified patients already matched to your specialty and availability
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule—only pay when you see patients
• Guaranteed ROI vs. gambling on marketing channels

Building Referral Networks

Beyond digital channels, relationship-based referrals work particularly well for psychiatrists entering weight management:

• Primary care physicians often lack bandwidth for ongoing GLP-1 management. Let local PCPs know you’re taking referrals—emphasize you’ll handle the weight piece and keep them updated on shared patients.
• Therapists and dietitians frequently see clients whose weight-loss progress stalls due to psychological factors or need medication support. They’ll gladly refer if they trust you’ll address both the medical and mental health aspects.
• Endocrinologists and bariatric surgeons sometimes need psychiatric clearance for their obesity patients or want to refer patients with complex mental health needs.

A simple outreach email or brief meet-and-greet coffee can establish these pipelines. Unlike competing for Google rankings, referral relationships compound over time with minimal ongoing effort.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

GLP-1 Telehealth Compliance: What You Actually Need to Know

Federal Framework: The Good News First

GLP-1 medications are not controlled substances. This is crucial because it means the Ryan Haight Act’s in-person examination requirement does not apply. You can legally prescribe semaglutide, tirzepatide, or liraglutide via pure telehealth—across state lines if properly licensed—without requiring an initial in-person visit.

This is fundamentally different from prescribing stimulants or benzodiazepines, where federal law still imposes restrictions (though temporary COVID-era flexibilities remain in effect for some controlled substances as of early 2026).

State Licensure Requirements

You must be licensed in the patient’s state. This is non-negotiable and applies to all telemedicine practice, not just GLP-1 prescribing.

For Psychiatrists (MD/DO):

• Full prescriptive authority in all 50 states
• Interstate Medical Licensure Compact (IMLC) membership expedites multi-state licensing in 42+ member states (including Texas, Pennsylvania, Illinois, and Florida—but notably not California or New York)
• Florida offers a special Out-of-State Telehealth Provider Registration that allows non-Florida physicians to practice telemedicine in Florida without full licensure (with some controlled substance restrictions that don’t affect GLP-1s)

For Psychiatric Nurse Practitioners (PMHNPs):

State scope-of-practice rules create significant variation:

Bottom line for PMHNPs: In Texas, Florida (for psych), Pennsylvania, and California (until 2026), you’ll need to establish a collaborative relationship with a supervising physician. Many telehealth platforms handle this by employing both MDs and NPs with built-in supervision structures. In New York and Illinois (if experienced), you can operate independently.

Standard of Care and Documentation

Whether in-person or via video, the standard of care remains the same. For GLP-1 prescribing, this means:

Initial Evaluation:

• Comprehensive medical history (prior weight-loss attempts, medical conditions, medications, surgical history)
• Mental health screening (depression, eating disorders, body image concerns)
• Calculate BMI and document indication for treatment
• Review contraindications (history of medullary thyroid carcinoma, pancreatitis, multiple endocrine neoplasia syndrome type 2)
• Baseline labs if indicated (A1c, fasting glucose, liver enzymes, lipids, TSH)
• Discuss lifestyle modifications (diet, exercise, behavioral strategies)
• Obtain informed consent including discussion of off-label use if prescribing Ozempic for obesity (vs. FDA-approved Wegovy), side effects, and costs

State-Specific Telehealth Rules:

• California requires verbal or written patient consent for telehealth services (document this in chart)
• Texas allows audio-only for mental health services but typically requires video for medical evaluations like weight management
• Florida has no in-person exam requirement for non-controlled substances but must meet standard of care via adequate telehealth evaluation
• New York mandates insurance parity for telehealth (useful for patient cost)
• Pennsylvania and Illinois have enacted comprehensive telehealth parity laws

No state specifically prohibits GLP-1 prescribing via telehealth. The key is conducting an evaluation that would satisfy the same medical necessity and safety standards as an in-person visit.

The Psychiatric Angle: Mental Health Monitoring

This is where psychiatrists have a unique advantage and responsibility. Early reports (2023) raised concerns about potential suicidal ideation linked to GLP-1 medications. By early 2026, the FDA reviewed extensive data and found no clear causal link, even directing removal of suicide warnings from labels.

However, as a psychiatrist, you should:

• Screen for mood disorders, eating disorders, and body dysmorphia during intake
• Monitor mood and anxiety symptoms at each follow-up
• Ask directly about suicidal thoughts if patients report mood changes
• Educate patients that rapid weight loss can sometimes affect mood
• Be prepared to adjust psychiatric medications if needed (e.g., antidepressants may need dose changes as weight drops)

This level of mental health integration is precisely what most weight-loss telehealth companies don’t provide. It differentiates your service and improves patient safety and outcomes.

Medication Sourcing and Pharmacy Compliance

You have two main options:

1. FDA-Approved Brand Medications (Wegovy, Saxenda, Zepbound):

• Highest quality assurance
• Easier insurance coverage (when available)
• Significantly more expensive ($1,000-1,500+/month retail)
• Intermittent supply shortages

2. Compounded Semaglutide/Tirzepatide:

• Lower cost ($200-400/month typically)
• Available through FDA-registered 503B compounding pharmacies
• Legal when brand drug is on FDA shortage list
• Must ensure pharmacy is properly licensed and uses FDA-compliant ingredients

The FDA has issued warnings about unregulated compounded GLP-1s from questionable sources. If partnering with a compounding pharmacy, verify:

• They’re licensed in relevant states
• They’re FDA-registered (503B outsourcing facility preferred)
• They provide certificates of analysis for drug purity
• They follow USP sterile compounding standards

Most telehealth platforms handle pharmacy relationships, which removes this compliance burden from individual providers. If you’re building an independent practice, working with a reputable compounding pharmacy partner or wholesale medication distributor is essential for both legal compliance and patient safety.

Cash vs. Insurance: The Economic Decision

The Insurance Reality

Here’s the uncomfortable truth: most insurance doesn’t cover GLP-1 medications for weight loss.

As of mid-2024:

• Only 13 state Medicaid programs covered GLP-1s for obesity (including California, Pennsylvania, and Illinois—but not Texas, Florida, or New York at that time)
• Most private plans explicitly exclude obesity medications or limit coverage to patients with diabetes
• When coverage exists, prior authorizations are extensive and often denied
• Medicare traditionally excluded weight-loss drugs (though pilot programs were under discussion in late 2025)

This creates a stark reality: most GLP-1 patients pay out-of-pocket for medications, even if they have insurance. A recent survey found that insurance coverage was the exception, not the rule, with cost being patients’ ‘primary concern.’

Cash-Pay Model Advantages

Many successful GLP-1 telehealth practices operate entirely on cash:

Patient Payment Structure:

• Monthly program fee ($100-300) covering consultations, monitoring, care coordination
• Medication cost ($200-1,500/month) depending on branded vs. compounded
• Some practices bundle everything into one monthly subscription

Provider Benefits:

• Simplified operations: No insurance contracts, no prior authorizations, no claims denials
• Predictable revenue: Recurring monthly income per patient
• Faster payment: Patients pay at time of service
• Higher per-visit revenue: Cash rates typically exceed insurance reimbursement
• No billing overhead: Minimal staff needed for payment processing

Patient Benefits:

• No insurance denials or coverage surprises
• Privacy (no insurance record of obesity treatment)
• Often lower total cost than brand medication copays
• Access to compounded options not covered by insurance

The key is transparency: clearly communicate costs upfront, offer payment plans if needed, and help patients understand this is a long-term investment (most patients need 12+ months of treatment).

Insurance Model Considerations

Some providers accept insurance for visits while medications remain patient-responsibility:

Billing Options:

• Standard E/M codes (99213-99215 for follow-ups, 99204-99205 for new patients)
• Medicare G0447 (intensive behavioral therapy for obesity) if you provide structured counseling
• Telehealth modifiers as required by payer

Advantages:

• Widens access to patients who need visit costs covered
• Can bill for behavioral counseling time
• Builds insurance panel for other services

Disadvantages:

• Lower reimbursement ($80-150 per visit vs. $150-300 cash)
• Administrative burden (credentialing, prior auths, claims management)
• Documentation requirements more rigid
• Still need to handle medication costs separately

Many psychiatrists choose a hybrid approach: Cash for GLP-1 program, insurance for psychiatric services. This maximizes both revenue and access.

The Economic Reality Check

A typical GLP-1 patient generates:

• 12-18 months of active treatment (average course)
• Monthly visits during first 3-6 months, then every 2-3 months
• 6-12 total visits over treatment course

Cash-pay example:

• $250 initial consult + $150/month follow-ups × 10 follow-ups = $1,750 total visit revenue
• If you mark up or provide medication: add $50-100/month margin × 15 months = $750-1,500 additional

Insurance example:

• $150 initial (after insurance adjustment) + $80 × 10 follow-ups = $950 total visit revenue
• Patient pays medication out-of-pocket (you earn nothing on meds)

The math favors cash-pay for revenue, but insurance models can work at scale if you have efficient billing infrastructure and want to serve populations who couldn’t otherwise afford care.

Building Scalable Workflows That Prevent Burnout

Here’s what kills providers in high-growth practices: every patient interaction requiring the same amount of physician time. You can’t scale that without working 70-hour weeks.

The solution: standardize, delegate, automate.

Phase 1: Standardized Intake

Create a comprehensive digital intake form that patients complete before their first appointment:

• Demographics and insurance (even if cash-pay, good to have)
• Complete medical history including all medications
• Weight history and prior weight-loss attempts
• Dietary patterns and exercise habits
• Mental health screening (PHQ-9, GAD-7, eating disorder screen)
• Review of systems focusing on contraindications
• Medication preferences and cost considerations

Why this matters: A well-designed intake form saves 15-20 minutes per initial consult. Instead of gathering basic information, you spend appointment time on medical decision-making and patient education.

Include automatic disqualifiers: Build in logic that flags patients who clearly don’t meet criteria (BMI too low, active eating disorder, contraindicated conditions) and routes them to a brief phone call rather than a full paid consultation. This protects both your time and patients who aren’t appropriate candidates.

Phase 2: Protocol-Driven Care

Develop clinical protocols for common scenarios:

Dose Titration Schedule:

• Semaglutide: 0.25mg weekly × 4 weeks → 0.5mg × 4 weeks → 1mg × 4 weeks → 1.7mg × 4 weeks → 2.4mg maintenance
• Clear guidance on when to hold dose (persistent nausea, not tolerating current dose)
• Standing orders for anti-nausea medications if needed

Side Effect Management:

• Template instructions for nausea, constipation, injection site reactions
• When to contact provider vs. manage at home
• Red flag symptoms requiring immediate contact

Follow-Up Schedule:

• Months 1-3: Monthly visits (15-20 minutes)
• Months 4-6: Every 6-8 weeks
• Month 6+: Every 2-3 months once stable

Progress Monitoring:

• Weekly weight tracking via app or patient portal
• Monthly body composition if available
• Quarterly metabolic labs (A1c, lipids) for patients with metabolic conditions

Having protocols means: You spend less cognitive energy on routine decisions. Medical assistants or nurses can implement protocols. You intervene only when patients deviate from expected course.

Phase 3: Leverage Your Team

You don’t have to do everything yourself.

Medical Assistant or RN responsibilities:

• Triage patient messages (most questions about side effects, injection technique, or scheduling don’t need physician response)
• Collect interim data before appointments (weight, BP, symptom questionnaires)
• Provide injection training via video or written materials
• Follow up on missed appointments or lab work
• Handle prior authorization paperwork if insurance billing

Health Coach or Dietitian (if budget allows):

• Monthly group sessions on nutrition, exercise, behavior change
• Individual coaching calls between physician visits
• Accountability for lifestyle modifications
• This offloads the ‘lifestyle counseling’ burden that can consume physician time

Psychiatric perspective: You already know the value of therapy + medication. Consider the same model here: you prescribe and monitor medication, while another professional handles intensive behavioral support.

ROI calculation: If a health coach costs $30/hour and conducts 4 patient calls per hour ($7.50 per patient), and this prevents you from spending 15 minutes on lifestyle counseling per patient ($50-75 opportunity cost of your time), you’re saving $40-65 per patient encounter. At scale with 100 patients, that’s $4,000-6,500/month in recovered physician time.

Phase 4: Technology and Automation

Telehealth platform essentials:

• Integrated video visits (no separate Zoom links to manage)
• E-prescribing with favorites/templates for common prescriptions
• Patient portal for asynchronous communication
• Automated appointment reminders (reduces no-shows)
• Payment processing integrated into workflow

Remote patient monitoring:

• Connected scales that automatically upload weight data
• Patient app for tracking food, exercise, symptoms
• Dashboard showing which patients are off-track (losing too fast, not losing, missing check-ins)

Why this matters: Instead of asking ‘how much have you lost?’ and manually charting it, you pull up a graph showing 12 weeks of daily weights. Visit time drops from 20 minutes to 12 minutes. Multiply that by 50 patients per month.

Template documentation:

• Create note templates for initial consults, routine follow-ups, and dose changes
• Use macros or dot phrases for common counseling
• Pre-built patient education materials (send link instead of explaining everything verbally)

Example: Your follow-up template auto-populates: weight trend from connected scale, current medication/dose, time until next dose increase per protocol, standard diet/exercise check-ins with dropdowns. You add medical decision-making notes and you’re done in 3 minutes of documentation instead of 10.

Phase 5: Group Visit Model

One of the most underutilized strategies: Group medical visits for stable patients.

How it works:

• Monthly 45-60 minute video call with 6-10 patients
• Review general progress, answer common questions, provide education topic (managing plateaus, exercise, etc.)
• Brief individual check-ins (2-3 minutes each) for dose adjustments
• Patients benefit from peer support and shared experience

Economics:

• 60 minutes of your time serves 8 patients = 7.5 minutes per patient
• Cash-pay: Charge $75-100 per patient for group visit (vs. $150 individual) = $600-800 for 60 minutes
• Insurance: Bill 99214 with group visit modifier if allowed (varies by payer)

Patients often prefer this: They don’t feel alone, get additional motivation from seeing others’ success, and value the community aspect. For the provider, it’s significantly more efficient than eight 15-minute individual appointments (which would be 120 minutes of appointment time plus 40 minutes of charting).

Phase 6: Set Hard Boundaries

This is where burnout prevention becomes personal:

Panel size limits:

• Start with 20-30 GLP-1 patients while you refine workflows
• Scale to 75-100 patients max if this is a part-time focus alongside psychiatric practice
• If GLP-1 becomes primary focus, 150-200 patients is manageable with good systems
• Beyond that, you need to add providers (hire an NP, bring on a partner)

Schedule control:

• Block specific days/times for GLP-1 appointments (e.g., Tuesday and Thursday afternoons)
• Keep Monday/Wednesday/Friday for psychiatric patients if maintaining dual practice
• Limit daily GLP-1 appointments (e.g., maximum 8 per day) to prevent fatigue from repetitive visits

Communication boundaries:

• Set patient expectations: routine questions answered within 24-48 hours via portal
• After-hours = emergencies only (and define what constitutes emergency)
• Use automated responses: ‘Your message has been received. Non-urgent questions will be answered within 2 business days.’
• Consider an answering service for after-hours calls

Vacation coverage:

• Partner with another provider for cross-coverage
• Telehealth platforms often provide backup coverage
• Set very clear protocols for what needs physician attention vs. what can wait
• Don’t check messages on vacation (actually don’t)

The data on this: Research shows that schedule flexibility and virtual practice options significantly reduce physician burnout. Paradoxically, giving yourself permission to work less often increases sustainable productivity over time.

Warning Signs You’re Overextended

Monitor yourself for:

• Dreading appointment notifications
• Cutting corners on documentation
• Irritability with patients asking routine questions
• Difficulty sleeping due to work stress
• Not taking time off
• Physical symptoms (headaches, GI issues, fatigue)

If you notice these: Immediately cap new patient intake, consider adding staff support, or reduce panel size. Burnout doesn’t improve on its own, and it significantly impacts both your well-being and patient care quality.

The goal isn’t just to build a successful GLP-1 practice. It’s to build one that’s financially rewarding, professionally satisfying, and personally sustainable for the long term.

Frequently Asked Questions

Can I prescribe GLP-1 medications if I’m a psychiatrist without additional obesity medicine certification?

Yes. GLP-1 medications are within the scope of practice for any licensed physician. Obesity is increasingly recognized as a chronic disease, and treating it with evidence-based medications falls under general medical practice. That said, pursuing additional education through CME courses in obesity medicine or behavioral weight management will increase your confidence and competence. Organizations like the Obesity Medicine Association offer online resources and certification programs if you want to formalize your expertise.

Do I need to see patients in-person initially, or can I start them on GLP-1s via telehealth only?

You can start patients entirely via telehealth. GLP-1 medications are not controlled substances, so federal law does not require an initial in-person visit. State laws vary, but no state specifically prohibits telehealth-only care for GLP-1 prescribing as long as you conduct an adequate evaluation (medical history, review contraindications, obtain informed consent) and meet the same standard of care as you would in person. States like Texas and Florida explicitly allow establishing physician-patient relationships via synchronous video for medication prescribing.

What if I’m a PMHNP? Can I prescribe GLP-1 medications independently?

It depends on your state. In New York (after 3,600 practice hours) and Illinois (after completing FPA requirements), experienced NPs can prescribe independently. In California (starting 2026 for 104 NPs), Texas, Pennsylvania, and Florida (for psychiatric NPs), you’ll need a collaborative agreement with a supervising physician. Many telehealth platforms facilitate these arrangements, or you can establish an independent collaboration agreement with a local physician if building your own practice. The good news: GLP-1s are non-controlled substances, so even in restrictive states, the supervision requirements are typically less burdensome than for controlled substance prescribing.

Should I accept insurance or operate cash-pay only for GLP-1 services?

Most successful GLP-1 telehealth practices operate on cash-pay because insurance coverage for obesity medications is limited and prior authorizations are burdensome. Cash-pay offers simpler operations, predictable revenue, and often higher per-visit income. However, accepting insurance for visits (while patients pay out-of-pocket for medications) can increase access for populations who need visit costs covered. A hybrid approach is common: cash for the weight-loss program, insurance for any concurrent psychiatric care. Consider your target population, administrative capacity, and revenue goals when deciding.

How do I handle patients who have both psychiatric and weight-loss needs?

This is actually your competitive advantage. You can integrate care in ways that single-focus providers cannot. Conduct combined appointments that address both psychiatric medication management and GLP-1 monitoring. Adjust psychiatric medications as weight changes (some antidepressants or mood stabilizers may need dose modifications). Screen for mood changes related to rapid weight loss. Provide behavioral strategies that support both mental health and weight management. Bill appropriately for the complexity of care provided. Many patients will greatly value having one provider who understands the interconnection between their mental health and physical health.

What’s a realistic timeline to build a patient panel of 50+ GLP-1 patients?

With active marketing or a telehealth platform partnership: 3-6 months to reach 50 patients, 6-12 months to reach 100. If relying solely on referrals from your existing psychiatric practice and word-of-mouth: 6-12 months to reach 50. The key variables are your marketing investment (joining a platform gives fastest patient flow), your availability (more appointment slots = faster growth), and your capacity to handle volume (if you can only see 3-4 new GLP-1 consults per week, growth is naturally slower). Most providers find the initial ramp-up period requires significant education and process refinement, then growth accelerates once systems are smooth.

How long do patients typically stay on GLP-1 medications?

Most patients require 12-18 months of active treatment to reach goal weight, followed by either maintenance dosing or gradual discontinuation with intensive lifestyle support. Some patients need longer-term or indefinite treatment to maintain weight loss, particularly those with significant metabolic dysfunction. From a practice perspective, plan for an average patient lifecycle of 15-18 months with regular visits, generating 8-12 billable encounters. Weight regain after stopping medications is common, so many patients return for ‘maintenance’ care or restart treatment, creating some recurring revenue even after initial treatment course.

What are the most common side effects I’ll be managing?

Gastrointestinal symptoms dominate: nausea (especially in first 4-8 weeks and after dose increases), occasional vomiting, constipation or diarrhea, and decreased appetite. Most resolve with time or dose adjustments. Injection site reactions are usually minor. Rare but serious: pancreatitis (educate patients on symptoms), gallbladder issues (if rapid weight loss), and potential medication interactions. As a psychiatrist, also monitor for mood changes, though the FDA has found no clear link to suicidal ideation, remaining vigilant given early reports is prudent. Having patient education materials and protocols for common side effects dramatically reduces anxiety and after-hours calls.

How do I manage patients who aren’t losing weight on GLP-1s?

First, check adherence (are they actually taking injections consistently?). Second, assess diet and exercise (medications are tools, not magic—lifestyle matters enormously). Third, consider dose optimization (some patients need higher doses). Fourth, screen for barriers: uncontrolled hypothyroidism, medications causing weight gain, significant metabolic dysfunction, or psychological factors like continued binge eating. Some patients are non-responders or slow responders (about 10-15% lose minimal weight). In these cases, consider switching to a different GLP-1 or combination therapy, or referring to a specialist. Setting realistic expectations upfront (average 15-20% body weight loss over 12-18 months, not overnight transformation) prevents disappointment.

Am I protected from liability if I prescribe GLP-1s outside my specialty training?

As a licensed physician, treating obesity with evidence-based medications is within your scope of practice. However, ensure your malpractice insurance covers this activity—inform your insurer that you’re providing weight management services. Follow standard of care: appropriate patient selection, informed consent, monitoring for side effects, and documentation. Avoid making unrealistic promises about results. If you encounter complex cases beyond your comfort level (e.g., patient with multiple contraindications or serious comorbidities), refer to obesity medicine specialists or endocrinology. Practicing within your competence and documenting appropriately provides strong liability protection. Completing CME in obesity medicine further demonstrates your commitment to practicing competently in this area.

The Bottom Line: Your Opportunity Without the Overwhelm

The GLP-1 revolution isn’t slowing down—it’s accelerating. With 20 million Americans already taking these medications and tens of thousands more starting every week, the patient demand will be there for years.

As a psychiatrist, you bring something most weight-loss providers don’t: understanding of behavior change, mental health expertise, and the ability to treat the whole person. That’s increasingly valuable as we recognize obesity as a complex biopsychosocial disease, not just a willpower problem.

The question isn’t whether you can build a successful GLP-1 practice. It’s whether you can build one without sacrificing your well-being.

The path forward:

1. Start small with existing patients who need help with weight
2. Choose your acquisition strategy: join a platform for fast patient flow, or build referral networks for steady organic growth
3. Standardize everything possible: intake, protocols, documentation, patient education
4. Delegate aggressively: hire support staff, use technology, consider team-based care
5. Set hard boundaries: limit panel size, control schedule, protect personal time
6. Monitor yourself: watch for burnout signs and adjust before you’re in crisis

The providers who thrive in this space aren’t necessarily the ones who see the most patients—they’re the ones who build sustainable systems that deliver great care without consuming their entire lives.

If you’re ready to explore this opportunity, platforms like Klarity Health offer a turnkey way to start: they handle patient acquisition, provide built-in telehealth infrastructure, manage scheduling, and give you control over when and how much you work. You pay only when you see patients, eliminating the financial risk of building a practice from scratch.

Whether you go that route or build independently, the opportunity is real. And with the right approach, you can tap into it without burning out.

References

1. Axios. ‘Just how many Americans are taking GLP-1s now.’ May 27, 2025. https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing

2. ConfectioneryNews. ‘GLP-1 drugs like Ozempic are reshaping health, diet and the food industry.’ October 20, 2025. https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/

3. Time. ‘The Heavy Cost of Using Weight-Loss Drugs to Get Skinny.’ August 22, 2025. https://time.com/7311517/cost-weight-loss-drugs-skinny/

4. Axios. ‘America’s doctors need more obesity medicine training.’ May 28, 2024. https://www.axios.com/2024/05/28/us-doctors-obesity-health-care-training

5. Axios. ‘States slow to cover GLP-1s for weight loss.’ November 5, 2024. https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss

6. California Board of Registered Nursing. ‘AB 890 Implementation FAQ.’ Updated November 2024. https://www.rn.ca.gov/practice/ab890

7. Medical Director Co. ‘Texas Weight Loss Clinic & Telehealth Compliance Guide.’ 2025. https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/

8. Wheel Health. ‘Florida Telehealth Regulations

Source:

• https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing#:~:text=More%20than%202,their%20original%20approved%20use
• https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/#:~:text=GLP,real%20number%20according%20to%20Kim
• https://forum.schizophrenia.com/t/psychiatrists-recommend-ozempic/311318#:~:text=Drugs%20pharmanewsintel
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=equivalent%20to%20in,FDA%2C%20pharmacy%2C%20and%20board%20alerts
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=,with%20chart%20review%2C%20plus%20meetings
• https://www.singleaimhealth.com/news/nurse-practitioner-collaborative-agreement-templates-50-state-guide#:~:text=In%20Pennsylvania%2C%20Certified%20Registered%20Nurse,the%20CRNP%20and%20the%20collaborating
• https://www.wheel.com/state-telehealth-regulations/florida#:~:text=Are%20There%20Online%20Prescription%20Restrictions,for%20Telehealth%20in%20Florida
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=most%20insurances%20cover%20the%20medication,A%20recent%20Annals%20of%20Internal
• https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss#:~:text=What%20they%20found%3A%20In%20all%2C,a%20primary%20concern%2C%20KFF%20found
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=But%20these%20medications%20were%20originally,diabetes%2C%20weight%20loss%20treatment%20is